KR930019696A - 탄수화물의 생산 방법 - Google Patents
탄수화물의 생산 방법 Download PDFInfo
- Publication number
- KR930019696A KR930019696A KR1019930003656A KR930003656A KR930019696A KR 930019696 A KR930019696 A KR 930019696A KR 1019930003656 A KR1019930003656 A KR 1019930003656A KR 930003656 A KR930003656 A KR 930003656A KR 930019696 A KR930019696 A KR 930019696A
- Authority
- KR
- South Korea
- Prior art keywords
- oligosaccharides
- following structure
- cell adhesion
- produced
- produce carbohydrates
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
- C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
- C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6464—Protein C (3.4.21.69)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/26—Preparation of nitrogen-containing carbohydrates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21069—Protein C activated (3.4.21.69)
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Veterinary Medicine (AREA)
- Microbiology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Materials Engineering (AREA)
- Polymers & Plastics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Compounds Of Unknown Constitution (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Diaphragms For Electromechanical Transducers (AREA)
- Amplifiers (AREA)
- Separation Using Semi-Permeable Membranes (AREA)
Abstract
본 발명은 펩타이드의 발현에 적당한 조헌하에서 글리코실화될 수 있는 펩타이드를 발현하는 인간 신장 293세포를 배양한 다음, 세포 또는 세포 배양물 상층액으로부터 펩타이드를 회수함으로서 서열 GalNAc (1-4) (Fuc(1-3)) GlcNAc를 가진 올리고당을 포함하는 펩타이드의 생산 방법에 관한 것이다.
본 발명은 또한 293 세포에서 생산된 펩타이드로부터 신규 올리고당을 더 단리하기 위한 방법을 포함한다. 생산된 펩타이드 및/또는 올리고당은 특정 세포 유착 수용체의 고 친화성 리간드로서 작용 하도록 사용될 수 있다. 펩타이드 및/또는 올리고당은 세포유착 및 염증을 방지하거나 감소시키기 위해 사용될 수 있다.
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
제1도는 293 세포에서 생산된 인간 단백질 C 분자상에서 발견된 주요 난수화물들의 크로마토그래프를 나타낸 것이다.
Claims (5)
- 하기 구조의 올리고당.
- 하기 구조의 올리고당.
- 하기 구조의 올리고당.
- 하기 구조의 올리고당.
- 하나이상의 약제학적으로 허용되는 담체, 부형제 또는 희석제와 함께 제1항, 2항, 3항 또는 4항 중 어느 한 항의 올리고당을 활성성분으로서 함유하는 소염제 조성물.※ 참고사항 : 최초출원 내용에 의하여 공개되는 것임.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US84986892A | 1992-03-12 | 1992-03-12 | |
US849,868 | 1992-03-12 |
Publications (1)
Publication Number | Publication Date |
---|---|
KR930019696A true KR930019696A (ko) | 1993-10-18 |
Family
ID=25306715
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019930003656A KR930019696A (ko) | 1992-03-12 | 1993-03-11 | 탄수화물의 생산 방법 |
Country Status (23)
Country | Link |
---|---|
EP (1) | EP0565241B1 (ko) |
JP (1) | JP3171506B2 (ko) |
KR (1) | KR930019696A (ko) |
CN (1) | CN1079967A (ko) |
AT (1) | ATE137241T1 (ko) |
AU (1) | AU661762B2 (ko) |
BR (1) | BR9301136A (ko) |
CA (1) | CA2091521A1 (ko) |
CY (1) | CY1947A (ko) |
CZ (1) | CZ39093A3 (ko) |
DE (1) | DE69302317T2 (ko) |
DK (1) | DK0565241T3 (ko) |
ES (1) | ES2088227T3 (ko) |
FI (1) | FI931086A (ko) |
GR (1) | GR3020406T3 (ko) |
HK (1) | HK132396A (ko) |
HU (1) | HUT69613A (ko) |
IL (1) | IL105018A0 (ko) |
MX (1) | MX9301344A (ko) |
NO (1) | NO930890L (ko) |
NZ (1) | NZ247105A (ko) |
YU (1) | YU16993A (ko) |
ZA (1) | ZA931723B (ko) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002081723A1 (fr) * | 2001-04-02 | 2002-10-17 | Keio University | Methode de production d'une chaine d'oligosaccharide |
FI20011664A (fi) | 2001-08-17 | 2003-02-18 | Carbion Oy | Syöpäpesifiset oligoskkaridisekvenssit ja niiden käyttö |
US7943763B2 (en) * | 2002-07-05 | 2011-05-17 | Otsuka Chemical Holdings Co., Ltd. | Process for preparing glycopeptides having asparagine-linked oligosaccharides, and the glycopeptides |
JP4790271B2 (ja) * | 2002-12-26 | 2011-10-12 | 康宏 梶原 | 3分岐型糖鎖アスパラギン誘導体、該糖鎖アスパラギン、該糖鎖およびそれらの製造方法 |
JP3884725B2 (ja) | 2003-06-03 | 2007-02-21 | 三菱電機株式会社 | 導波管装置 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5009889A (en) * | 1987-12-31 | 1991-04-23 | Oklahoma Medical Research Foundation | Treatment of dysfunctional vascular endothelium using activated protein C |
-
1993
- 1993-03-10 HU HU9300687A patent/HUT69613A/hu unknown
- 1993-03-10 NZ NZ247105A patent/NZ247105A/en unknown
- 1993-03-10 CZ CZ93390A patent/CZ39093A3/cs unknown
- 1993-03-10 ZA ZA931723A patent/ZA931723B/xx unknown
- 1993-03-11 IL IL105018A patent/IL105018A0/xx unknown
- 1993-03-11 FI FI931086A patent/FI931086A/fi not_active Application Discontinuation
- 1993-03-11 YU YU16993A patent/YU16993A/sh unknown
- 1993-03-11 BR BR9301136A patent/BR9301136A/pt not_active Application Discontinuation
- 1993-03-11 KR KR1019930003656A patent/KR930019696A/ko not_active Application Discontinuation
- 1993-03-11 MX MX9301344A patent/MX9301344A/es not_active Application Discontinuation
- 1993-03-11 AU AU35199/93A patent/AU661762B2/en not_active Ceased
- 1993-03-11 CN CN93104040A patent/CN1079967A/zh active Pending
- 1993-03-11 JP JP05056193A patent/JP3171506B2/ja not_active Expired - Fee Related
- 1993-03-11 CA CA002091521A patent/CA2091521A1/en not_active Abandoned
- 1993-03-11 NO NO93930890A patent/NO930890L/no unknown
- 1993-03-12 ES ES93301878T patent/ES2088227T3/es not_active Expired - Lifetime
- 1993-03-12 DK DK93301878.0T patent/DK0565241T3/da active
- 1993-03-12 EP EP93301878A patent/EP0565241B1/en not_active Expired - Lifetime
- 1993-03-12 AT AT93301878T patent/ATE137241T1/de not_active IP Right Cessation
- 1993-03-12 DE DE69302317T patent/DE69302317T2/de not_active Expired - Fee Related
- 1993-03-12 CY CY194793A patent/CY1947A/xx unknown
-
1996
- 1996-06-12 GR GR960401581T patent/GR3020406T3/el unknown
- 1996-07-18 HK HK132396A patent/HK132396A/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
JP3171506B2 (ja) | 2001-05-28 |
IL105018A0 (en) | 1993-07-08 |
HUT69613A (en) | 1995-09-28 |
YU16993A (sh) | 1996-02-19 |
CZ39093A3 (en) | 1994-03-16 |
MX9301344A (es) | 1993-09-01 |
AU3519993A (en) | 1993-09-16 |
HU9300687D0 (en) | 1993-05-28 |
CN1079967A (zh) | 1993-12-29 |
EP0565241A1 (en) | 1993-10-13 |
CY1947A (en) | 1993-03-12 |
EP0565241B1 (en) | 1996-04-24 |
DK0565241T3 (da) | 1996-05-28 |
GR3020406T3 (en) | 1996-09-30 |
BR9301136A (pt) | 1993-09-28 |
NO930890D0 (no) | 1993-03-11 |
CA2091521A1 (en) | 1993-09-13 |
DE69302317D1 (de) | 1996-05-30 |
DE69302317T2 (de) | 1996-09-19 |
HK132396A (en) | 1996-07-26 |
NO930890L (no) | 1993-09-13 |
AU661762B2 (en) | 1995-08-03 |
JPH0625302A (ja) | 1994-02-01 |
NZ247105A (en) | 1994-11-25 |
ES2088227T3 (es) | 1996-08-01 |
FI931086A0 (fi) | 1993-03-11 |
FI931086A (fi) | 1993-09-13 |
ATE137241T1 (de) | 1996-05-15 |
ZA931723B (en) | 1994-09-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA199700347A1 (ru) | Сульфатированный олигосахарид, его применение для лечения теплокровных животных и фармацевтическая композиция на его основе | |
RU95114376A (ru) | Нитроэфиры, обладающие фармакологической активностью, и способ их получения | |
AU2342284A (en) | Tetracycline activity enhancement | |
DE3854194T2 (de) | Monoklonale antikörper gegen glykosyliertes albumin, hybride zellinien, die diese antikörper produzieren, sowie deren verwendung. | |
ES2167370T3 (es) | Activacion inmunologica a traves de una terapia intermitente con interleucina-2. | |
CA2085354A1 (en) | Ether lipid-nucleoside covalent conjugates | |
KR930019696A (ko) | 탄수화물의 생산 방법 | |
KR900000335A (ko) | 히드록시알킬시스테인 유도체 및 이를 함유하는 거담제 | |
TR199700772T1 (xx) | �ubuk ba�lant�. | |
ATE41785T1 (de) | Membranoese polysaccharide, verwendbar insbesondere als arzneimittel und verfahren zu ihrer herstellung. | |
DK0707473T3 (da) | Orale farmaceutiske præparater omfattende et protein eller et peptid, et antistof og polymerkugler | |
Iwase et al. | Aggregated human serum immunoglobulin A1 induced by neuraminidase treatment had a lower number of O-linked sugar chains on the hinge portion | |
ATE265861T1 (de) | Antikörper gegen l-selectin zur vorbeugung von multiplem organversagen und akuter organschädigung | |
Walker-Nasir et al. | Isolation and partial characterization of surface components of cell line MDA-MB-231 derived from a human metastatic breast carcinoma | |
RU94046321A (ru) | Моноклональные муриновые антиидиотипические антитела, способ их получения и их применение, способы иммунизации и фармацевтический состав на их основе | |
PT791056E (pt) | Enzima de degradacao de lipidos | |
RU93004705A (ru) | Олигосахариды, фармацевтическая композиция, применение олигосахаридов | |
KR900014598A (ko) | 변형된 pe_40의 제조 | |
ASAHI et al. | Tryptic digestion of rabbit γ-globulin | |
FR7058M (ko) | ||
KR870008535A (ko) | "밤"가루(율분) | |
Czarnetzki et al. | Modulation of eosinophil chemotaxis and eosinophil chemotactic factor release by concanavalin A | |
EZAWA et al. | Mechanism of immunosuppression by a murine non-specific suppressor T cell line, SB-1 | |
EBUKURO | Discussion on the auditory design factors for working environment | |
IT8821370A0 (it) | Perfezionamenti nella costruzione di pompe per combustibile. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WITN | Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid |